PAR.AX
Price:
$0.42
Market Cap:
$163.56M
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.[Read more]
Industry
Biotechnology
IPO Date
2015-08-19
Stock Exchange
ASX
Ticker
PAR.AX
According to Paradigm Biopharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 145.98M. This represents a change of -16.08% compared to the average of 173.95M of the last 4 quarters.
The mean historical Enterprise Value of Paradigm Biopharmaceuticals Limited over the last ten years is 167.54M. The current 145.98M Enterprise Value has changed 8.61% with respect to the historical average. Over the past ten years (40 quarters), PAR.AX's Enterprise Value was at its highest in in the June 2020 quarter at 572.02M. The Enterprise Value was at its lowest in in the January 2015 quarter at 0.
Average
167.54M
Median
99.05M
Minimum
4.65M
Maximum
552.99M
Discovering the peaks and valleys of Paradigm Biopharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.37%
Maximum Annual Enterprise Value = 552.99M
Minimum Annual Increase = -70.77%
Minimum Annual Enterprise Value = 4.65M
Year | Enterprise Value | Change |
---|---|---|
2024 | 67.47M | -70.77% |
2023 | 230.79M | 19.29% |
2022 | 193.47M | -48.45% |
2021 | 375.32M | -32.13% |
2020 | 552.99M | 345.44% |
2019 | 124.14M | 67.85% |
2018 | 73.96M | 182.83% |
2017 | 26.15M | -1.25% |
2016 | 26.48M | 469.85% |
2015 | 4.65M | 2.37% |
The current Enterprise Value of Paradigm Biopharmaceuticals Limited (PAR.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
163.91M
5-year avg
284.01M
10-year avg
167.54M
Paradigm Biopharmaceuticals Limited’s Enterprise Value is less than PolyNovo Limited (1.41B), less than AVITA Medical, Inc. (208.15M), less than Opthea Limited (540.23M), less than Mesoblast Limited (2.05B), less than Volpara Health Technologies Limited (284.13M),
Company | Enterprise Value | Market cap |
---|---|---|
1.41B | $1.44B | |
208.15M | $380.10M | |
540.23M | $923.44M | |
2.05B | $3.22B | |
284.13M | $291.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paradigm Biopharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Paradigm Biopharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Paradigm Biopharmaceuticals Limited's Enterprise Value?
What is the highest Enterprise Value for Paradigm Biopharmaceuticals Limited (PAR.AX)?
What is the 3-year average Enterprise Value for Paradigm Biopharmaceuticals Limited (PAR.AX)?
What is the 5-year average Enterprise Value for Paradigm Biopharmaceuticals Limited (PAR.AX)?
How does the current Enterprise Value for Paradigm Biopharmaceuticals Limited (PAR.AX) compare to its historical average?